{"url_path":"/sec/lmed/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1477960/0001477932-26-003348-index.html","accession_number":"0001477932-26-003348","cik":"0001477960","ticker":"LMED","issuer_name":"LataMed AI Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1477960/0001477932-26-003348-index.html","primary_entity_key":"0001477960","primary_entity_name":"LataMed AI Corp."},"word_count":48,"has_tables":true,"body_markdown":"**Item 5. Other Information.**\n\n \n\nDuring the quarter ended March 31, 2026, no director or officer of the Company adopted, modified, or terminated any Rule 10b5-1 trading arrangement or any non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.\n\n \n\n \n\n17\n\n*Table of Contents*"}